Multivalent Small-Molecule Pan-RAS InhibitorsMatthew Welsch, Brent R. Stockwell, Anna Kaplan et al.|Cell|2017Cited by 283
PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase InhibitorsMichael E. Stokes, David Surguladze, Matthew J. Betzenhauser et al.|Clinical Cancer Research|2023Cited by 27
A multicenter, open-label, phase 1a study of HC-5404 in patients with advanced solid tumors.Arkadiusz Z. Dudek, J. L. Mesías Iglesias, Joyce O’Shaughnessy et al.|Journal of Clinical Oncology|2024Cited by 13
Activation of GCN2 By HC-7366 Results in Significant Anti-Tumor Efficacy As Monotherapy and Overcomes Resistance Mechanisms When Combined with Venetoclax in AMLFeven Tameire, Nandita Bose, Nicholas Collette et al.|Blood|2023Cited by 3